Trustmark Corp

TRMK retains a long-term uptrend above the rising 200-day SMA, but the medium-term has shifted into a Stage 4 decline with a decisive support failure and bearish EMA crossover. Price is trading below the 9, 20, and 50-day averages, and while RSI is near oversold, we avoid chasing extended downside. We will trim positions into any corrective rally toward the former support zone around $45.18–$46.50 rather than initiating new shorts at current levels.

• ↑Q2 EPS $1.08 vs est, revenue +4.8% YoY.
• ↑Loan balances +4.5% YoY, deposits +6.3% YoY.
• ↓Adjusted EPS ex one-offs shows only modest core growth.